Cargando…
785. Bacterial Co-infection and Empirical Antibiotic Therapy in Patients with COVID-19
BACKGROUND: Understanding the rate and composition of bacterial co-infection is important to determine antibiotic therapy in SARS-CoV-2 infection, but those vary according to healthcare settings and regional differences. We evaluated the rate of bacterial co-infection in hospitalized patients with C...
Autores principales: | Lee, Jiyoung, Jung, Jiwon, Kim, Min Jae, Chong, Yong Pil, Kim, Sung-Han, Lee, Sang-Oh, Choi, Sang-Ho, Kim, Yang Soo, Bae, SeongMan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752067/ http://dx.doi.org/10.1093/ofid/ofac492.046 |
Ejemplares similares
-
Bacterial Co-Infection and Empirical Antibacterial Therapy in Patients With COVID-19
por: Lee, Jiyoung, et al.
Publicado: (2023) -
1082. Clinical Characteristics and Vertical Transmission of Pregnant Women with SARS-CoV-2 Infection and Their Neonates
por: Lee, Jiyoung, et al.
Publicado: (2022) -
411. Comparison of clinical outcomes between early and delayed transplantation after SARS-CoV-2 infection
por: Reum Kim, A, et al.
Publicado: (2023) -
Risk Factors for Mortality in Patients with Klebsiella pneumoniae Carbapenemase-producing K. pneumoniae and Escherichia coli bacteremia
por: Seo, Hyeonji, et al.
Publicado: (2021) -
61. Short- versus prolonged-courses of antimicrobial therapy for patients with uncomplicated Pseudomonas aeruginosa bloodstream infection
por: Bae, Moonsuk, et al.
Publicado: (2021)